Fibrosis around the smooth muscle of asthmatic airway walls leads to irreversible airway obstruction. Bronchial epithelial cells release GM-CSF in asthmatics and are in close proximity to airway smooth muscle cells (ASMC). The findings in this study demonstrate that GM-CSF induces confluent prolonged serum deprived cultures of ASMC to increase expression of collagen I and fibronectin. GM-CSF also induced
INTRODUCTION
A functional abnormality in asthma is obstruction to airflow as a consequence of recruitment of inflammatory cells, mucus plugging and airway wall thickening (17, 30).
The airways are thickened by inflammatory cell infiltrate consisting of eosinophils, lymphocytes and mast cells, mucosal edema and vasodilation (17, 30) . Although many of these changes are reversible (30) , airway obstruction in asthmatics may also be irreversible due to airway remodeling (30) . Remodeling of airways occurs when myofibroblasts just beneath the bronchial epithelium proliferate and synthesize increased amounts of collagens I, III, V and fibronectin (30) . In addition, airway remodeling occurs from increases in collagens, elastins, fibronectin, laminin, hyaluronan and versican around airway smooth muscle cells (ASMC) (27) . ASMC may become hyperplastic and hypertrophied which also contribute to structural changes, airway narrowing and obstruction (27) . Based on observations made on the pathogenesis of fibrosis at other sites, it is speculated that a number of cytokines and growth factors may be important in regulating the recruitment and proliferation of fibroblasts and connective tissue synthesis by fibroblasts, myofibroblasts and ASMC (24, 33) . The source of cytokines that regulate fibroblasts could be the structural cells themselves such as bronchial epithelial cells and ASMC (3) . Alternatively, the inflammatory cells recruited to the airways or serum protein and platelets that leak into the airways could be additional sources of fibrogenic cytokines (3, 17) .
Two cytokines of particular interest in the context of airway remodeling are granulocyte macrophage-colony stimulating factor (GM-CSF) and transforming growth factor-beta (TGF-). GM-CSF is a 22-25 kDa homodimeric glycoprotein originally described to induce proliferation and differentiation of bone marrow cells (13, 15) . GM-CSF is produced and released by a number of cells (13, 35) , such as fibroblasts, keratinocytes, bronchial epithelial cells, vascular and airway smooth muscle cells (6, 7, 13, 25, 26, 35) . Using immunohistochemistry and Northern analysis, the expression of GM-CSF is increased in the bronchial epithelial cells (BEC) of asthmatics compared to non-asthmatics (26) . Isolated BEC from asthmatic airways release more GM-CSF than BEC from non-asthmatic controls (26) . It is speculated that in asthma the increased presence of GM-CSF in the airways leads to survival of eosinophils, which have been demonstrated to have an important role in regulating a number of events in asthma (6, 7, 25, 26) . Recently, an additional effect of GM-CSF has been described demonstrating the induction of connective tissue synthesis (8, 31, 36) . For example, in a rat model, subcutaneous instillation of GM-CSF led to fibroblast accumulation and stimulation of alpha-smooth muscle actin synthesis in myofibroblasts (31) . In another rat model, intratracheal administration of an adenovirus containing the GM-CSF gene led to irreversible pulmonary fibrosis (36). The mechanism by which GM-CSF induces collagen synthesis is not well understood but could be due to induction of TGF-, a regulator of connective tissue synthesis (4, 24, 33) . GM-CSF induced mRNA of TGF-1 by vascular smooth muscle cells (29) and leiomyoma cells (10) . GM-CSF also caused myometrial smooth muscle cells to release TGF-1 (10).
TGF-is a multifunctional polypeptide (4, 24, 33 ) that is present as 3 isoforms in mammals but TGF-1 is the isoform most commonly associated with disorders characterized by inflammation and fibrosis (4) . Signal transduction of TGF-1 is mediated when TGF-1 associates with TGF-receptor type II (T R-II), a 73 kDa serine threonine receptor that is constitutively phosphorylated (5, 14) . Upon binding TGF-1, T R-II phosphorylates TGF-receptor type I (T R-I), a 53 kDa protein, leading to signal transduction mediated by a number of intracellular proteins that include the Smads (5, 14, 28) . TGF-receptor type III (T R-III), or betaglycan, is a 250-350 kDa proteoglycan that also binds TGF-1 but has no definite signaling capability (5, 14) . However, the association of TGF-with T R-III enhances the interaction of TGF-with T R-II and subsequent signal transduction (5, 14) . Using immunohistochemistry we had previously demonstrated that all isoforms of TGF-and T R-I, T R-II were expressed by ASMC of human and rat lungs (21, 23). We had also demonstrated that subconfluent bovine ASMC or mechanically wounded monolayers of ASMC release biologically active TGF-1, that in an autocrine fashion induced collagen I synthesis (12) . Furthermore, the addition of TGF-1 to ASMC also led to collagen synthesis in a dose dependent fashion (12) . Despite the fibrogenic effects of TGF-1 on ASMC, previous studies using Northern blot analysis and immunohistochemistry have not demonstrated evidence of increased expression of TGF-1 in ASMC of patients with asthma compared to nonasthmatic airways (2, 11, 32) . Furthermore, there has been no correlation of expression of TGF-1 with the severity of asthma and airway remodeling (11) . Unlike our observations, these findings do not demonstrate the release of biologically active TGF-1 in a model simulating ASMC injury (12) . The release of active TGF-1 is important in autocrine regulation of collagen synthesis by ASMC (12) .
In addition, the aforementioned studies do not provide any evidence on the regulation of T Rs, which may be equally important in TGF-1 mediated effects.
Bronchial epithelial cells, which express and release GM-CSF during episodes of asthma, are in close proximity to ASMC. It is then conceivable that GM-CSF previously demonstrated to induce TGF-1 (10, 29) might regulate ASMC to synthesize and release TGF-1, which in turn, would induce collagen synthesis in the ASMC layer of bronchi.
In this study, we demonstrate that GM-CSF induces collagen I and fibronectin expression by bovine confluent prolonged serum deprived cultures of ASMC in a dose-dependent were approaching confluence in some parts of the dish at 6-10 days after explanting, the explants were removed, and the ASMC were passaged with 0.05% trypsin/0.53 mM EDTA. For the experiments, the ASMC in passage 1-3 were grown in MEM with 10%
MATERIALS AND METHODS

Materials
FCS and antibiotic-antimycotic reagents to confluence, and then changed to serum-free MEM containing antibiotics and ITS (10 ug/ml of insulin, 5.5 ug/ml of transferring and 5 ng/ml of sodium selenite, from Sigma) for 10 days prior to the addition of GM-CSF, with or without 10 -4 M dexamethasone (SABEX, Boucherville, QC, Canada). It is of note that we had previously demonstrated that when ASMC are subconfluent in culture, they release biologically active TGF-1 (12) . In these conditions, the release of TGF-1 results in the synthesis of collagen I (12) . However, when ASMC were grown to confluence and kept in serum free conditions for 10 days there was no active TGF-1 present in the CM (12) . Such conditions also had minimal or no collagen I synthesis (12) and were considered suitable to evaluate the effects of GM-CSF on the release of TGF-1 or connective tissue synthesis by GM-CSF. Henceforth when we refer to confluent monolayers of ASMC, the term refers to prolonged serum deprived confluent ASMC.
Collection of conditioned media:
At various times after incubation of cells, the overlying conditioned media (CM) was removed, stored in sterile siliconized eppendorf tubes in the presence of the protease inhibitors including leupeptin 5µg/ml (Boehringer Mannheim), aprotinin 5µg/ml (Sigma), pepstatin A 5µg/ml (Sigma) and 1mM PMSF (Sigma) and frozen at -86°C until ready for use. room temperature. The antibody was diluted to a working concentration of 2 ug/ml and 100 ul of the preparation was added to each well. After washing with wash buffer and blocking with block buffer, 100 µl of sample or the standard, rh TGF-1 was added and incubated for 2 hours at room temperature. The plate was washed prior to adding 100 ul of the detection antibody (biotinylated chicken anti-human TGF-1). The TGF-1 binding was colored by streptavidin-HRP and the optical density was read using a microplate reader at 450 nm with correction at 540 nm.
TGF-1 receptor assay by flow cytometry:
Western blotting and immune detection: After collection of the CM, ASMC
were washed with phosphate buffered saline (PBS) and then detached by trypsinization.
Cell numbers were determined using a hemocytometer. Whole cell protein was extracted on ice with triple-detergent lysis buffer (50 mM Tris-HCl pH 8.0, 0.15 M NaCl, 1%
Triton -X-100, 0.1% SDS, 5mg/ml sodium deoxycholate) in the presence of the protease inhibitors (as above). In addition to these inhibitors, the samples used for detection of pSmad-2 were extracted in the presence of NaF (1 mM) and Na 3 VO 4 (1 mM), potent phosphatase inhibitors. Protein concentration was calculated using the Bradford method with a BioRad Protein Assay Reagent (BioRad; Hercules, CA). Protein extracts were separated by SDS-PAGE on polyacrylamide SDS gels (gel concentrations were: 8% for collagen I, fibronectin and T R-III, 10% for T R-II and p-Smad-2, and 12% for T R-I and CTGF) as per Laemmli's method and then transferred onto a PVDF membrane (BioRad) using CAPS transfer buffer (25 mM CAPS, pH 10, 20% methanol) (12) . The equal loading of proteins was confirmed prior to immunoblotting, using Ponceau S Staining Solution (Sigma). Briefly, after transfer of the protein from SDS-PAGE, the PVDF membrane was immersed in Ponceau S Staining Solution for 5 minutes, rinsed, and the protein bands visualized. Once equal loading was established, the membrane was prepared for immunoblotting. After blocking with 5% milk in Tris-buffered saline containing 0.05% Tween-20 overnight at 4°C, the membrane was incubated with primary antibody at various dilutions. The dilution for collagen I was 1:3000, fibronectin 1:3000, T R-I 1:500, T R-II 1:500, T R-III 1:600, CTGF 1:500, p-Smad-2 1:500 for 1 hour at room temperature or overnight at 4°C. This was followed by incubating the blots with a secondary antibody (Santa Cruz) at a dilution of 1:8000 for 1 hour at room temperature.
The proteins on the membrane were then immunodetected by the ECL system 
Statistical analysis:
The results were expressed as mean ± standard error of the mean (SEM). All p-values (2-tailed) were based on the Wilcoxon signed rank test.
Results were considered statistically significant when p<0.05.
RESULTS
GM-CSF regulation of connective tissue expression and release of TGF-1 by ASMC:
We had previously demonstrated that addition of TGF-1 to monolayers of ASMC induced collagen I synthesis in a dose dependent fashion (12) . Similar to TGF-1, the presence of GM-CSF also induced collagen I synthesis in a dose dependent manner (Figures 1 A, B) . In addition, TGF-1 increased the expression of fibronectin by a greater magnitude than GM-CSF at equivalent amount of 0.05 and 0.1 ng/ml. We next detected by Western analysis ( Figure 3B ). Next we determined if there was an increase in T R-III associated to TGF-1 by immunoprecipitating ASMC proteins using TGF-1
antibody followed by Western analysis using anti-T R-III or anti-TGF-1 antibody.
ASMC protein extracts immunoprecipitated with TGF-1 all expressed the same quantity of TGF-1 ( Figure 3C , lower blots). ASMC cultured alone had a minor quantity of T R- that mediate intracellular signals of the TGF-superfamily (28) . ASMC cultured with GM-CSF had induction of p-Smad-2 compared to untreated controls ( Figure 3D ).
Induction of connective tissue proteins by TGF-is mediated by CTGF, a 33-38 kDa cysteine rich protein (16). To confirm that connective tissue synthesis was mediated by
TGF-1, the protein from ASMC was immunoblotted with anti-CTGF antibodies.
ASMC cultured with GM-CSF had an induction of CTGF ( Figure 3D ). To further confirm that GM-CSF induced above effects are via T Rs, GM-CSF treated ASMC were cultured with or without T R-II antibody, which interrupts the TGF-1/T R-II interaction. The increased p-Smad-2 by GM-CSF was inhibited in the presence of 20 ug/ml of T R-II antibody ( Figure 3E ). It is of note that in the presence of GM-CSF, the magnitude of increases in the expression of T Rs, collagen I, fibronectin, p-Smad-2 and CTGF is modest. However, the results are highly reproducible. Furthermore, there is a statistically significant difference in the expression of all these proteins when ASMC treated with GM-CSF are compared to ASMC receiving no treatment. 
Effects of dexamethasone on GM-CSF induced expression of T Rs
Smad-2, CTGF, T R-I, T R-II, and T R-III between the extracts from ASMC treated
with dexamethasone (10-4 M) and with normal saline (Table 1) . However, the presence of dexamethasone inhibited collagen I and fibronectin expression induced by GM-CSF (Fig. 4A, B) . However, the findings of others do not take into account that biologically active TGF-1 may be released during ASMC injury (12) , or that there may be induction of T Rs by cytokines present in asthmatic airways (11, 32) . A cytokine reported to be released by BEC during an episode of asthma is GM-CSF (26) . Based on the current findings, the release of GM-CSF by bronchial epithelium, which is in direct contact with ASMC, The current findings demonstrate a unique interaction between two totally different cytokines, GM-CSF and TGF-1, commonly found at sites of injury and fibrosis (8, 13, 19, 20, 21, 23, 25, 29, 31, 33, 36, 37) . For example, in models of pulmonary fibrosis induced by the anti-neoplastic antibiotic bleomycin, there is increase of both an adenovirus carrying the gene for GM-CSF to rats, there was an increase in TGF-1 in the bronchoalveolar lavage fluid (BALF) (12) . In those instances where both GM-CSF and TGF-1 are increased, the induction of the T Rs by GM-CSF could lead to a synergistic effect of GM-CSF and TGF-1 on cells for connective tissue synthesis.
In conclusion, we have demonstrated that GM-CSF, a prevalent cytokine released by BEC in asthma stimulates confluent prolonged serum-deprived culture of ASMC to The data presented is from 9 (for A) and 4 (for B) different experiments. 
